Retraction Notice to “Effect of subcutaneous lidocaine–hydroxypropyl-β-cyclodextrin (HP-β-CD) on quality of life in patients with post-COVID condition: a 36-week observational interrupted time series study” [eClinicalMedicine 90(2025) 103681]
20260 citationsJournal Articlegold Open Access
Field-Weighted Citation Impact: 0.00
Retraction Notice to “Effect of subcutaneous lidocaine–hydroxypropyl-β-cyclodextrin (HP-β-CD) on quality of life in patients with post-COVID condition: a 36-week observational interrupted time series study” [eClinicalMedicine 90(2025) 103681] | Researchclopedia